A randomized trial comparing compression, perclose proglide™ and angio-seal VIP™ for arterial closure following percutaneous coronary intervention: The CAP trial

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 1, 2008, Pages 1-5

  Martin, Jack L ^a   Pratsos, Antonis ^a   Magargee, Edward ^b   Mayhew, Kim ^a   Pensyl, Catherine ^a   Nunn, Mary ^a   Day, Francis ^a   Shapiro, Timothy ^b  

^a BRYN MAWR HOSPITAL   (United States)

^b LANKENAU HOSPITAL   (United States)

Author keywords

Hemostasis; Vascular access; Vascular complications

Indexed keywords

ADULT; AGED; ARTERY; ARTICLE; CLINICAL TRIAL; COMPRESSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MOBILIZATION; PATIENT SATISFACTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TREATMENT FAILURE; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CATHETERIZATION, PERIPHERAL; EARLY AMBULATION; FEMALE; FEMORAL ARTERY; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRESSURE; PROSPECTIVE STUDIES; PUNCTURES; SUTURES; TIME FACTORS;

EID: 38549168988     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21333     Document Type: Article

References (10)

1. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary intervention following hemostasis with manual compression vs. arteriotomy closure devices. J Am Coll Cardiol 2001;38:638-641.
2. Resnic FS, Blake GJ, Ohno-Machado L, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb/IIIa inhibitors. Am J Cardiol 2001;88:493-496.
3. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and II b/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol 2002;40:78-83.
4. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 2004;16:243-246.
5. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures; a meta-analysis. J Am Coll Cardiol 2004;44:1200-1209.
6. Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988;11:1-11.
7. Ellis SG, Bhatt D, Kapadia S, et al. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:541-545.
8. Arora N, Kucher N, Matheny ME, et al. Retroperitoneal hemorrhage following interventional cardiac catheterization procedures: predictors, outcomes, association with vacular closure devices and healthcare costs. J Am Coll Cardiol 2006;47:34B.
9. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-782.
10. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005;96:1200-1206.